MedJ Takes You to WCLC 2025
Maurice Pérol, MD, Lyon Cancer Research Center, France. Sharing Cutting-Edge Advances at WCLC, Offering an In-Depth Interpretation of the FLAURA2 Study, and Revealing the HARMONi Study's New Strategy to Overcome EGFR Resistance!